Synthekine

About:

Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.

Website: https://synthekine.com

Twitter/X: synthekine

Top Investors: Deerfield, RA Capital Management, Samsara BioCapital, The Column Group, Emerson Collective

Description:

Synthekine is an engineered cytokine therapeutics company that creates selective immunotherapies to improve cancer and inflammatory disease treatment paradigms. Using knowledge of cytokine structure and function, the company develops therapeutics that maximize cytokine efficacy while avoiding toxic side effects. Synthekine is developing a broad and deep pipeline of product candidates by leveraging principles of cytokine partial agonism and immunological specificity across multiple protein engineering platforms. Modified cytokines, cytokine-enhanced cell therapies, and surrogate cytokine agonists are among the novel immunotherapies.